Are there any FDA‑approved, evidence‑based dietary supplements proven to lower hypertension?

Potassium-Enriched Salt Substitutes Are the Only FDA-Regulated, Evidence-Based "Supplement" for Lowering Blood Pressure

The strongest recommendation is to use potassium-enriched salt substitutes (75% sodium chloride/25% potassium chloride) rather than traditional dietary supplements, as these have the most robust evidence for reducing blood pressure and cardiovascular events 1. However, it's critical to understand that no traditional dietary supplements (vitamins, herbs, or nutraceuticals) are FDA-approved specifically for treating hypertension—FDA approval applies only to pharmaceutical drugs, not supplements.

The Evidence Hierarchy

Potassium-Enriched Salt Substitutes: The Strongest Evidence

The 2024 Hypertension journal guidelines 1 provide the most compelling evidence for any "supplement-like" intervention:

• Randomized controlled trials demonstrate reductions in blood pressure AND cardiovascular events and deaths—not just surrogate markers
• These products should be recommended to all hypertensive patients unless they have:
  • Advanced kidney disease
  • Current potassium supplement use
  • Potassium-sparing diuretic use
  • Other contraindications to potassium

This represents a paradigm shift because it addresses both sides of the sodium-potassium equation simultaneously, which traditional supplements cannot achieve.

Traditional Dietary Supplements: Modest and Inconsistent Effects

The 2025 AHA/ACC guidelines 2 and supporting research reveal that traditional supplements show only modest blood pressure reductions:

Supplements with some evidence (but NOT FDA-approved):

• Omega-3 fatty acids (EPA/DHA): Reduce systolic BP by ~1.5 mmHg and diastolic BP by ~1 mmHg overall 3. Effects are stronger in untreated hypertensives (systolic -4.5 mmHg, diastolic -3.1 mmHg) but require ≥2 grams daily 3

• Beetroot juice/Inorganic nitrates: Show consistent effects, particularly when combined with aerobic exercise at ~50% heart rate reserve 4, though the 2024 network meta-analysis 5 found effects smaller than placebo in some comparisons

• Coenzyme Q10, garlic, and vitamin C: Have possible benefits 6 but evidence is dated (2012) and less robust than newer interventions

• Resveratrol and curcumin: Show promise in older or metabolically compromised populations 4, but the 2024 network meta-analysis 5 found resveratrol's diastolic effects were actually smaller than placebo

Critical Caveats and Pitfalls

The FDA Approval Misconception

No dietary supplement is FDA-approved for treating hypertension. The FDA regulates supplements under the Dietary Supplement Health and Education Act (DSHEA), which is fundamentally different from drug approval. Supplements cannot legally claim to treat, prevent, or cure diseases.

Supplements That RAISE Blood Pressure

Avoid these entirely 6:

• Ephedra
• Siberian ginseng
• Bitter orange
• Licorice

The Magnitude Problem

Even the best-studied supplements reduce blood pressure by only 1-5 mmHg 7—far less than the 9/5 mmHg reduction seen with antihypertensive medications 7. This matters for morbidity and mortality outcomes.

Quality and Consistency Issues

The 2024 network meta-analysis 5 noted significant risk of bias in 7 of 12 included studies, and none of the pairwise differences between supplements reached statistical significance. This underscores the inconsistent quality of supplement research.

Practical Algorithm for Clinical Decision-Making

For patients asking about supplements for hypertension:

1. First-line recommendation: Potassium-enriched salt substitute (75% NaCl/25% KCl) 1

   • Check: Kidney function (eGFR), current medications (K-sparing diuretics), baseline potassium
   • If contraindicated → proceed to step 2

2. Adjunctive considerations (NOT replacements for medication):

   • If patient refuses medications or has borderline BP: Consider omega-3 fatty acids ≥2g daily 3, particularly if untreated hypertensive
   • If patient is older (≥60 years): Nicotinamide mononucleotide shows modest SBP reduction in this age group 8
   • If patient exercises regularly: Beetroot juice before aerobic training may provide additive benefit 4

3. Always emphasize: These are adjuncts, not replacements for proven antihypertensive medications when indicated by guidelines 2

The Bottom Line on "Evidence-Based"

The term "evidence-based" for supplements must be qualified: While some supplements show statistically significant BP reductions in meta-analyses, the clinical significance is modest, the quality of evidence is variable 5, and most importantly, only potassium-enriched salt substitutes have demonstrated reductions in hard outcomes (cardiovascular events and mortality) 1. All other supplements show only surrogate marker improvements (BP numbers) without proven impact on what matters most—preventing heart attacks, strokes, and death.

The 2024 guideline review 1 explicitly calls for updating clinical guidelines to provide consistent advice about potassium-enriched salt, recognizing it as the only supplement-type intervention with sufficient evidence for strong recommendation.